trial results forecast a favorable outcome of the Phase II trial. This killed whole-HIV vaccine is a unique approach in HIV vaccinology. This approach will present the native structural ... robust adaptive immune…
Obtaining a practical, efficacious vaccine against HIV has been a public health priority for over 30 years. A guiding principle for vaccine design has been that cellular and humoral immunity ... sustaining such a…
strenuous efforts are being made in different parts of the world to advance the HIV vaccine R&D agenda, Africa has been largely playing a spectator role. Considering that Africa ... would expect Africa to be in the…
affordable vaccine against HIV is one. Indeed South Africa is at the forefront of HIV Vaccine research. It has produced the first candidate HIV vaccine in the third world. Various ... institutions are involved in HIV…
centers. Objective: Prevalence and incidence of HIV-infection, knowledge and willingness to participate in HIV vaccine trial among residents of East Shoa Zone, Ethiopia, 2010. Methods: This cross sectional study…
took more than 30 years of hard laboratory and clinical work toward HIV vaccine development. Efficacy trials of RV144 and their results revealed that HIV vaccine is accomplishable. Clinical trials ... antibodies and to…
Introduction: Racial / ethnic minorites are underrepresented in actual HIV vaccine trials in North America, and willingness to participate (WTP) and retention in an HIV vaccine trial may differ from Whites ... Methods…
pursuit of a safe and effective HIV vaccine holds lifesaving potential for people globally; unfortunately, a number of ongoing HIV vaccine safety and efficacy trials are being shortened paused ... measures to…
Vaccines remain the best option, but the development of a safe and effective preventive HIV vaccine has defied decades of research. Over 30 products have been tested in more than ... broadened the understanding of HIV…
African Americans in the United States (U.S.) are disproportionately affected by HIV. Developing an HIV vaccine is an important part of the HIV prevention and treatment toolkit and may help ... contribute to ending the…
structure of bNmAbs. Although several trials were done in the field of HIV vaccination, none of them showed great success. However, there are other approaches paving the way for delivering ... cell infection. Within…
recent modest success in Thailand of the RV144 HIV vaccine trial has shown that it is possible to produce an HIV vaccine. However, developing a vaccine that achieves improved safety ... assay standardization that will…
Despite major advances in antiretroviral therapy against HIV-1, an effective HIV vaccine is urgently required to reduce the number of new cases of HIV infections in the world. Vaccines ... plethora of information that…
Plans are in the pipeline to commence field trials to determine the efficacy of HIV vaccines amongst the Nigerian population. This study was conducted to assess the willingness to participate ... subjects in HIV vaccine…
Introduction: One of the challenges HIV vaccine researchers face is the grapple with the practical need to recruit, engage and sustain the research participants in the HIV vaccine trials ... participants level of…
negative young adult participants (study I). Research subjects who participated in a phase II HIV vaccine trial, answered to the same semi-structured questionnaire and participated in 12 in-depth ... belief model was…
extent of the HIV epidemic, the potential benefit of, and moral reason for, HIV vaccine development is enormous, especially if we have greater reason to benefit the worst off. These ... Regenmortel has argued that…
negative young adult participants (study I). Research subjects who participated in a phase II HIV vaccine trial, answered to the same semi-structured questionnaire and participated in 12 in-depth ... belief model was…
btaining a practical, efficacious vaccine against HIV has been a public health priority for over 30 years. A guiding principle for vaccine design has been that cellular and humoral immunity ... sustaining such a…
Since the discovery of HIV vaccine three decades back, the quest for HIV vaccines has remained unquenched. There has been a transition of preferred approaches from candidates capable of inducing ... breadth to…
HIV specific CD8 T cells induced. We have recently developed two novel HIV vaccines that co-express i) IL-13R2 which can transiently inhibit IL-13 activity ... responders in the RV144 trail, which offer good promise…
also valuable insights on the possible immunologic correlates of vaccine protection. Currently, the HIV vaccine research landscape has been rejuvenated by two major developments. On one hand, there has been ... clinical…
Medical Research Council (MRC). SAAVI co-ordinates and support the development of testing of HIV Vaccines in South Africa with the aim to find an affordable, effective and locally relevant ... HIV vaccine. SAAVI works…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.